SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?

To: FNS who wrote (716)6/3/1998 10:25:00 AM
From: David S.  Respond to of 965
 
I found out why Merrill thinks this stock will go to $70. Unless I read it wrong, being short could be a big mistake. In a recent research report, they desribe Avakine as an orkin drug. As we all know, insects are a big problem - even fire ants and killer bees are expanding their territories. If Avakine can take care of just one of these problems - killer bees, fire ants, or even cockroaches, this stock is going to $170, not $70.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News